Probiotic Ingredients Market Expected To Witness A Substantial Growth Of $3.56 Billion By 2025: Grand View Research Inc.
The global probiotic
ingredients market size is
projected to reach USD 3.56 billion by
2025, according to a new report by Grand View Research, Inc. It is expected
to expand at a CAGR of 7.9% over the
forecast period. Increasing consumer awareness regarding preventive healthcare
has emerged as a key market driver. Probiotics play a great role in preventive
healthcare as they prevent the occurrence of a disease by strengthening the
immune system of the body.
The demand for nutraceuticals & functional
foods is expected to witness an upward surge owing to consumers opting for
immunity boosting supplements during the COVID-19 pandemic. Furthermore, a
decline in the consumption of poultry, meat and seafood products across the
globe is expected to increase the demand for plant and animal-based protein
supplements in the near future. The report will account for Covid19 as a key
market contributor.
Another significant factor bolstering
the product demand across the globe is the increasing investments by key market
players in R&D activities with respect to the development of efficient
probiotic strains. There have been advancements in the delivery systems used
for delivering probiotics in the human body. Efficient strains have been
developed that work in compatibility with these delivery systems. This allows a
high number of probiotics to reach the body parts such as the intestines, thus
increasing their effectiveness.
To Request Sample Copy of this report, click the link:
https://www.grandviewresearch.com/industry-analysis/probiotic-ingredients-market/request/rs1
Companies have developed and
identified proprietary strains for specific applications. These strains meet
different requirements possessed by different medical conditions. Lactobacillus
fermentum VRI-003 PCC and Lactobacillus rhamnosus HN001 are used to cure
Eczema. Lactobacillus acidophilus NCFM and Bifidobacterium animalis lactis
Bi-07 strains are used to cure cold. Lactobacillus acidophilus, Lactobacillus
reuteri RC-14, and Lactobacillus rhamnosus GR-1 are effective for treating
vaginal infection.
Further key findings from the report suggest:
·
In terms of ingredient,
bacteria emerged as the largest segment with a revenue of USD 1.74 billion in
2018. The segment is expected to continue its dominance over the forecast
period
·
In terms of application,
probiotic dietary supplements segment is anticipated to expand at the fastest
CAGR of 8.2% over the forecast period, attributable to the increasing demand
for these supplements from various industries including pharmaceutical,
nutraceutical, and functional supplements
·
In terms of end use, human
probiotics segment is expected to lead the market over the forecast period,
with animal probiotics segment at a distant second. Advancement in oral
probiotic market has contributed to the growth of the human probiotics segment
·
Asia Pacific is anticipated to
witness the fastest CAGR of 8.4% over the forecast period. Led by countries
such as India, China, and Japan, the Asia Pacific probiotic ingredients market
is driven by the increasing adoption of the product predominantly in infant
formula
·
The market is highly
competitive with a sizable number of domestic and international players sharing
the market space. Product innovation and mergers and acquisitions are among the
key strategies deployed by prominent players to withstand competition
·
The key market participants are
Ganeden, Inc.; Probiotical S.p.A.; Biocodex, Inc.; Sabinsa Corporation; BioGaia
AB; Chr. Hansen Holding A/S; and Lallemand, Inc. among others
Europe emerged as the largest
probiotic ingredients market in 2018, with a revenue of USD 742.2 million.
Rising awareness concerning gut and immune health, prevalence of gut-related
diseases, and the presence of geriatric population are some of the key factors
contributing significantly to the regional market growth. Increasing
consumption of animal probiotic ingredients is anticipated to further fuel the
regional expansion. Increasing focus on mortality reduction and growth of
animals coupled with the need for feed conversion efficiency is expected to
trigger the regional demand.
The market participants have been
engaging in mergers and acquisitions in a bid to increase their market share.
For instance, in December 2017, Royal DSM, a science-based company
headquartered in Netherlands announced the acquisition of Biocare Copenhagen
A/S, a Denmark-based food supplements manufacturing and supplying company. The
acquisition was intended to expand the former’s product offerings of probiotic
gut health ingredients.
Have
a Query? Ask Our Expert:
https://www.grandviewresearch.com/inquiry/3852/ibb
Grand View Research has segmented the global probiotic
ingredients market on the basis of ingredient, application, end use, form:
Probiotic Ingredient Outlook (Revenue, USD
Million, 2014 - 2025)
·
Bacteria
o
Lactobacilli
o
Bifidobacterum
o
Streptococcus
o
Other Genus
·
Yeast
·
Spore Formers
Probiotic Ingredients Application Outlook
(Revenue, USD Million, 2014 - 2025)
·
Probiotic Food & Beverages
·
Probiotic Dietary Supplements
·
Animal Feed Probiotic
Probiotic Ingredients End Use Outlook
(Revenue, USD Million, 2014 - 2025)
·
Human Probiotics
·
Animal Probiotics
Probiotic Ingredients Form Outlook
(Revenue, USD Million, 2014 - 2025)
·
Dry Form
·
Liquid Form
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For
More Information:www.grandviewresearch.com
Comments
Post a Comment